Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Q&A
  3. FYI post-approval change/preclearance exemption/what requires review/PAAB scope
  4. 376 - We have a PAAB-approved fax blast for pharmacists. Our marketing team wants to remove the product codes and prices and send the piece to physicians. This is the only change…would the revised fax blast need to go through PAAB-review? If it does not, is it ok to keep the PAAB logo on the piece?
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

376 - We have a PAAB-approved fax blast for pharmacists. Our marketing team wants to remove the product codes and prices and send the piece to physicians. This is the only change…would the revised fax blast need to go through PAAB-review? If it does not, is it ok to keep the PAAB logo on the piece?

Scheduled Pinned Locked Moved FYI post-approval change/preclearance exemption/what requires review/PAAB scope
1 Posts 1 Posters 189 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • Jennifer CarrollJ Offline
    Jennifer CarrollJ Offline
    Jennifer Carroll
    wrote on last edited by
    #1

    Per the Submission Guidance document on our website at: http://www.paab.ca/resources/pdfs/code-revision/Guidance_on_Submission_Process.pdf The described change would require review (as would any removal or addition of drug content for example). See the sections “FYIs” and “All Other Post Approval Changes”. This industry reviewed document lists the types of changes which would not require review. Given the resemblance to prior APS, we’d do what we can to expedite the process for you. Call a member of our admin team to flag the file accordingly.

    1 Reply Last reply
    0
    Reply
    • Reply as topic
    Log in to reply
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes


    • Login

    • Don't have an account? Register

    • Login or register to search.
    • First post
      Last post
    0
    • Categories
    • Recent
    • Tags
    • Popular
    • Users
    • Groups